Cargando…

Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy

About half of advanced stage head and neck squamous cell carcinoma (HNSCC) patients can be cured by chemoradiotherapy. Patient outcome may be partially determined by the genetic alterations in HNSCC, rendering these alterations promising candidate prognostic factors and/or therapeutic targets. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vossen, David M., Verhagen, Caroline V.M., van der Heijden, Martijn, Essers, Paul B.M., Bartelink, Harry, Verheij, Marcel, Wessels, Lodewyk F.A., van den Brekel, Michiel W.M., Vens, Conchita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521057/ https://www.ncbi.nlm.nih.gov/pubmed/30934880 http://dx.doi.org/10.3390/cancers11040445

Ejemplares similares

Ovarian cancer‐derived copy number alterations signatures are prognostic in chemoradiotherapy‐treated head and neck squamous cell carcinoma
por: Essers, Paul B.M., et al.
Publicado: (2020)

Role of variant allele fraction and rare SNP filtering to improve cellular DNA repair endpoint association
por: Vossen, David M., et al.
Publicado: (2018)

Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma
por: Verhagen, Caroline V.M., et al.
Publicado: (2018)

Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation
por: van der Heijden, Martijn, et al.
Publicado: (2020)

Acute Hypoxia Profile is a Stronger Prognostic Factor than Chronic Hypoxia in Advanced Stage Head and Neck Cancer Patients
por: van der Heijden, Martijn, et al.
Publicado: (2019)

Phase I feasibility study of Olaparib in combination with loco-regional radiotherapy in head and neck squamous cell carcinoma
por: Navran, Arash, et al.
Publicado: (2023)

Identification of a novel ATM inhibitor with cancer cell specific radiosensitization activity
por: Dohmen, Amy J.C., et al.
Publicado: (2017)

Postoperative chemoradiotherapy in gastric cancer – a phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy
por: Jansen, E P M, et al.
Publicado: (2007)

(99m)Tc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy
por: Hoebers, Frank J. P., et al.
Publicado: (2007)

Feasibility of a supervised and home‐based tailored exercise intervention in head and neck cancer patients during chemoradiotherapy
por: Kok, Annemieke, et al.
Publicado: (2022)

The clinical outcomes of elderly esophageal cancer patients who received definitive chemoradiotherapy
por: Lu, Hao-Wei, et al.
Publicado: (2020)

Comparative Study Between Peristomal Patches in Patients with Definitive Tracheostomy
por: Lansaat, Liset, et al.
Publicado: (2018)

Correction: Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy
por: Keek, Simon, et al.
Publicado: (2020)

Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy
por: Keek, Simon, et al.
Publicado: (2020)

The Prediction of Biological Features Using Magnetic Resonance Imaging in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
por: van der Hulst, Hedda J., et al.
Publicado: (2023)

Improving decision making in larynx cancer by developing a decision aid: A mixed methods approach
por: Petersen, Japke F., et al.
Publicado: (2019)

Robust BRCA1‐like classification of copy number profiles of samples repeated across different datasets and platforms
por: Schouten, Philip C., et al.
Publicado: (2015)

Model integrating CT-based radiomics and genomics for survival prediction in esophageal cancer patients receiving definitive chemoradiotherapy
por: Cui, Jinfeng, et al.
Publicado: (2023)

Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer
por: Heukelom, Jolien, et al.
Publicado: (2013)

Flexible co‐data learning for high‐dimensional prediction
por: van Nee, Mirrelijn M., et al.
Publicado: (2021)

Definitive Chemoradiotherapy for Advanced Pulmonary Sarcomatoid Carcinoma
por: Takeda, Kazuya, et al.
Publicado: (2016)

Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib
por: de Haan, R., et al.
Publicado: (2019)

Knowledge driven decomposition of tumor expression profiles
por: van Vliet, Martin H, et al.
Publicado: (2009)

A scale-space method for detecting recurrent DNA copy number changes with analytical false discovery rate control
por: van Dyk, Ewald, et al.
Publicado: (2013)

Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancer
por: Kwak, Yoo-Kang, et al.
Publicado: (2014)

Treatment outcomes of definitive chemoradiotherapy for patients with hypopharyngeal cancer
por: Nakahara, Rie, et al.
Publicado: (2012)

Chemoradiotherapy Combined with Brachytherapy for the Definitive Treatment of Esophageal Carcinoma
por: Mangesius, Julian, et al.
Publicado: (2023)

The lymphocyte–monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy
por: Liu, Xuemei, et al.
Publicado: (2017)

Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer
por: Rees, J, et al.
Publicado: (2015)

The efficacy and safety of definitive concurrent chemoradiotherapy for non‐operable esophageal cancer
por: Dreyfuss, Alexandra D., et al.
Publicado: (2021)

Optimizing Survival Predictions of Hypopharynx Cancer: Development of a Clinical Prediction Model
por: Arends, Coralie R., et al.
Publicado: (2019)

Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancer
por: Blazeby, J M, et al.
Publicado: (2014)

Dose coverage and breath-hold analysis of breast cancer patients treated with surface-guided radiotherapy
por: Dekker, Janita, et al.
Publicado: (2023)

SDF-1α predicts poor prognosis in patients with locally advanced esophageal squamous cell carcinoma receiving definitive concurrent chemoradiotherapy
por: Chen, Yen-Hao, et al.
Publicado: (2022)

Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer
por: Tougeron, D, et al.
Publicado: (2008)

Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer
por: Atsumi, Kazushige, et al.
Publicado: (2013)

Chemoradiotherapy as Definitive Treatment for Elderly Patients with Head and Neck Cancer
por: Müller von der Grün, Jens, et al.
Publicado: (2018)

Salvage Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) for T4b Esophageal Cancer After Definitive Chemoradiotherapy
por: Defize, I. L., et al.
Publicado: (2020)

TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth
por: Palit, Sander AL, et al.
Publicado: (2019)

A comparison of univariate and multivariate gene selection techniques for classification of cancer datasets
por: Lai, Carmen, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_44u5j2vtavgl03ln38ravc8t23